Sofinnova Partners has successfully closed its $200M Digital Medicine Fund, marking a significant stride in life sciences venture capital. Spearheaded by Edward Kliphuis and Simon Turner, the fund is set to invest in startups focused on enabling technologies, analytics, and innovative treatment solutions.

With this considerable financial infusion, Sofinnova aims to nurture breakthrough digital medicine ventures by offering not just capital, but also specialized expertise and access to robust healthcare networks.